Related Experiment Video
Updated: Jan 10, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Patient characteristics, valve surgery and 1-year mortality in left-sided Staphylococcus aureus infective
Sikander Tajik Nielsen1, Peter Laursen Graversen2, Katra Hadji-Turdeghal2
1Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark sikander.tajik.nielsen.02@regionh.dk.
Insights
Surgery for Staphylococcus aureus infective endocarditis (SA-IE) was associated with lower 1-year mortality, but not significantly different in-hospital mortality. Patient characteristics and disease severity varied between surgical and non-surgical groups.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Outcomes
Background:
- Staphylococcus aureus infective endocarditis (SA-IE) has high mortality rates (30-40%).
- Guidelines suggest surgery for SA-IE, but comparative outcome data are limited.
- Lack of robust evidence hinders definitive treatment strategy selection.
Purpose of the Study:
- To compare outcomes between surgical and non-surgical treatment for left-sided SA-IE.
- To analyze in-hospital and 1-year mortality in SA-IE patients.
- To evaluate the impact of surgical intervention on SA-IE patient survival.
Main Methods:
- Retrospective cohort study using the Danish endocarditis registry (2016-2021).
- Identified 918 patients with left-sided SA-IE, categorized into surgical (17%) and non-surgical (83%) groups.
- Analyzed baseline characteristics and mortality using Cox regression.
Main Results:
- Surgical patients were younger, had fewer comorbidities but presented with more severe disease (larger vegetations, sepsis, emboli).
- Crude in-hospital mortality was lower in the surgical group (17% vs. 28%).
- Adjusted in-hospital mortality showed no significant difference, but 1-year mortality was significantly lower in surgical patients (HR 0.61).
Conclusions:
- Surgical intervention for SA-IE was linked to reduced 1-year mortality.
- Despite initial disease severity, surgical patients experienced better long-term survival.
- Heterogeneity in patient populations limits definitive conclusions on treatment superiority.
Background:
Staphylococcus aureus infective endocarditis (SA-IE) remains a serious condition, with in-hospital mortality rates ranging between 30% and 40%. While current guidelines suggest surgery may be considered in all SA-IE cases, robust data comparing outcomes between patients undergoing surgery and those receiving medical therapy alone are scarce.
Methods:
Using the NatIonal Danish endocarditis stUdieS registry, we identified all patients with left-sided SA-IE between 2016 and 2021. Patients were categorised into two groups: surgical and non-surgical. Baseline characteristics were assessed, and in-hospital mortality was analysed using crude estimates and multivariable Cox regression.
Results:
Of 918 patients identified, 160 (17%) patients underwent surgery (median age 63.7 years; 73% male), and 758 (83%) were treated non-surgically (median age 75.0 years; 58% male). Surgical patients had fewer comorbidities, including diabetes (18% vs 27%) and congestive heart failure (6% vs 19%). Surgical patients presented at admission with more severe conditions, including larger vegetations (56% vs 21%), sepsis (53% vs 33%) and emboli (24% vs 10%). Crude in-hospital mortality was lower in the surgical group (17% vs 28%), as was 1 year mortality (21% vs 45%). After adjusting for confounders, there was no significant difference in adjusted in-hospital mortality between the groups (HR 0.75 (95% CI 0.47 to 1.19)); however, 1-year mortality was statistically significantly lower in surgical patients (HR 0.61 (95% CI 0.41 to 0.91)).
Conclusion:
In patients with SA-IE, surgical patients were younger and had fewer comorbidities, but had more severe disease status at admission, compared with non-surgical patients. Surgery was associated with lower 1-year mortality, but the heterogeneity of this patient population limits firm conclusions about the superiority of either treatment strategy.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction

